Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
289.40
+3.20 (1.12%)
Jul 9, 2025, 5:29 PM CET

Xvivo Perfusion AB Market Cap

Xvivo Perfusion AB has a market cap or net worth of 9.02 billion as of July 9, 2025. Its market cap has decreased by -33.36% in one year.

Market Cap
9.02B
Enterprise Value
8.73B
Revenue
854.98M
Ranking
n/a
PE Ratio
66.12
Stock Price
289.40

Market Cap Chart

Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 9.02B, an increase of 2,325.43%. That is a compound annual growth rate of 28.40%.

History

DateMarket Cap% Change
Jul 8, 20259.02B-41.47%
Dec 30, 202415.40B48.41%
Dec 29, 202310.38B90.12%
Dec 30, 20225.46B-33.55%
Dec 30, 20218.22B-8.90%
Dec 30, 20209.02B99.42%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Swedish Orphan Biovitrum AB 98.92B
Sectra AB 67.75B
Getinge AB 51.75B
Asker Healthcare Group AB 41.10B
Camurus AB 40.11B
Medicover AB 39.56B
AddLife AB 22.62B
Vimian Group AB 21.99B
Market Cap Rankings